期刊文献+

SV40感染滴度测定方法的建立及高滴度病毒的制备 被引量:2

Development of Determination Method for Infectious Titer of SV40 and Preparation of High Titer Virus
下载PDF
导出
摘要 目的建立稳定的SV40感染滴度测定方法,制备高滴度SV40,用于生物制品病毒清除/灭活工艺的验证。方法通过分析不同细胞感染SV40后出现病变的时间、病变程度及产毒量,确定SV40敏感细胞株。分析维持液、细胞培养时间、病毒吸附时间等对病毒滴定测定的影响,建立SV40滴度测定的方法。并分析病毒感染后不同时间及细胞不同部位SV40滴度的差异,制备大量的高滴度SV40。结果与Vero、Vero76及VeroE6细胞相比,CV-1细胞对SV40高度敏感,细胞病变出现时间最早,病变最明显,产毒量最高。SV40滴度与病毒接种前细胞的培养时间、细胞接种量和维持液无明显相关,但吸附时间对病毒滴度有一定的影响。病毒的最佳吸附时间为120 min。接种病毒后48 h收集细胞沉淀,所获得的SV40滴度最高,平均为8.81 lg CCID50/ml。结论已建立了稳定的SV40滴度测定方法,并制备了高滴度SV40,为病毒清除/灭活工艺验证研究奠定了基础。 Objective To develop a stable determination method for infectious titer of SV40 and prepare high titer SV40 used for the validation of virus removal/inactivation procedure of biologics. Methods Analyze the time when CPE appears, the degree of CPE and virus yield of various cells after infection with SV40 to screen SV40-sensitive cell strain. Analyze the effects of maintain medium, time for culture and time for virus adsorption on the virus titration to develop a method for determination of SV40 titer. Analyze the variation of SV40 titers at various hours after infection and at various sites of cells to prepare high titer SV40 in a large quantity. Results Compared with Vero, Vero 76 and VeroE6 cells, CV-I cells were more sensitive to SV40,in which the CPE appeared earlier and was more significant,and the virus yield was higher. SV40 virus titer showed no significant relationship to the time for culture of cells before inoculation, concentration of cells inoculated and cell maintain medium. However, the time for virus adsorption showed a certain influence on virus titer. The optimal time for virus adsorption was 120 min. The mean titer of SV40 harvested 48 h after inoculation was 8.81 CCID50/ml. Conclusion A stable method for determination of SV40 titer was developed,and high titer SV40 was prepared, h laid a foundation of validation of virus removaL/inaetivation procedure of biologies.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第2期143-146,共4页 Chinese Journal of Biologicals
关键词 SV40 CV-1细胞 细胞病变 病毒滴度 Simian vacuolatin virus 40( SV40 ) CV- 1 cells Cytopathic effect Virus titer
  • 相关文献

参考文献6

  • 1Narayan P,Weiner LP. Biological properties of two strains of simian virus 40 isolated from patients with progressive muhifoeal leukoencephalopathy. Infect Immun, 1974,10( 1 ) : 173-179.
  • 2Fields BN, Knipe DM, Howley PM, et al. Fields Virology. 3rd edition. Philadelphia: Lippincott-Raven Publishers, 1996.
  • 3曹增,孙强明,孙娟,蒋鸿超,李洪钊,别俊,张光明,孙茂盛,戴长柏.SV40病毒的培养、增殖及鉴定[J].生物技术,2005,15(3):46-49. 被引量:1
  • 4刘馨,杨涛,洪超,崔萍芳,孙茂盛,候宗柳.猴病毒SV40的灭活及鉴定[J].动物医学进展,2003,24(6):86-88. 被引量:1
  • 5邢进,王春玲,贺争鸣,邢瑞昌,金潇,郭羽,李桂平.猴空泡病毒(SV40)PCR检测方法的建立与初步应用[J].实验动物科学与管理,2005,22(4):18-22. 被引量:1
  • 6黄祯详.医学病毒学基础及实验技术[M].北京:科学出版社,1990.142-148.

二级参考文献27

  • 1李华,胡凝珠,谢忠平,袁兵,洪超,段维国,崔萍芳,钱兴丽,何跃.脊髓灰质炎减毒活疫苗中SV40和泡沫病毒的检测[J].中国生物制品学杂志,2004,17(4):229-232. 被引量:2
  • 2刘馨,孙茂盛,侯宗柳.SV40(Simain Virus40)的分子生物学研究进展[J].国外医学(病毒学分册),2002,9(3):65-68. 被引量:4
  • 3Barbanti-Brodano G, Sabbioni S, Martini F, et al. Simian virus 40 infection in hamans and association with human diseases: results and hypotheses[J].Virology,2004,318(1):1-9.
  • 4Murinda SE, Rashid KA, Roberts RF. In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays[J].J Food Prot, 2003,66(5):847-853.
  • 5GalateauSalle F, Bidet P,Iwatsubo Y, at al. Detection of SV 40 like DNA sequences in pleural meso thelioma, bronchopulmonary carcinoma and other pulmonary diaeases[J].Dev Biol Stand, 1998,94:155-164.
  • 6Testa J R, Carbone M, Hirvonen A, et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesothelioma[J].Cancer Res,1998,58:4505-4509.
  • 7Botchan M, Grodzicker T. DNA Tumor Viruses: Control of Gene Expresion and Replication[M].2nd edition. New York: Cold Spring Harbor Laboratory Press,2000.1-17.
  • 8Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease[J]. J Nail Cancer Inst, 1999,91(2):119-134.
  • 9Vilchez RA, Butel JS. Lack of serologic evidence for prevalent simian virus 40 infection in humans[J].J Nail Cancer Inst, 2004,96(8):633-635.
  • 10Brian Mahy, Hillar Kangro. Virology Methods Manual[M].London: Academic Preaa, 1996.47-70.

共引文献2

同被引文献22

  • 1赵慧,段鸿元,李晓萸,赵卓,康晓平,秦鄂德.细胞密度和感染复数对SARS病毒在Vero细胞中增殖的影响[J].生物技术通讯,2005,16(3):274-275. 被引量:10
  • 2刘馨,孙茂盛.轮状病毒VP4基因的原核表达、蛋白纯化及动物免疫试验[J].动物医学进展,2006,27(12):88-90. 被引量:6
  • 3Estes MK, Graham DY. Identification of rotaviruses of different origins by the plaque-reduction test. Am J Vet Res, 1980, 41 (1): 151-152.
  • 4Awachat PS, Kelkar SD. Unexpected detection of simian SA11-human reassortant strains of rotavirus G3P[8] genotype from diarrhea epidemic among tribal children of Western India. J Med Virol, 2005, 77 ( 1 ): 128-135.
  • 5Coelho C, Vinatea CE, Heinert AP, et al. Comparison between specific and multiplex reverse transcription-polymerase chain reaction for detection of hepatitis A virus, poliovirus and rotavirus in experimentally seeded oysters. Mem Inst Oswaldo Cruz, 2003, 98 (4): 465-468.
  • 6Fred EH, Human rotavirus HCR3A and method of growing said rotavirus: US , 5610049. 1997-11-03.
  • 7Small C, Barro M, Brown TL, et al. Genome heterogeneity of SA11 rotavirus due to reassortment with"O"agent.Virology, 2007, 359(2): 415-424.
  • 8Dreyer G, Vandorpe T, Smeets A, et al. Triple negative breast cancer:clinical characteristics in the different histo- logical subtypes[J]. Breast, 2013, 22(5) :761-766.
  • 9Gupta S. Triple negative breast cancer:a continuing chal- lenge [ J]. Indian J Med Paediatr Oncol, 2013, 34( 1 ) : 1-2.
  • 10Lopez S M, Hodgson M C, Packianathan C, et al. Deter- minants of the tumor suppressor INPP4B protein and lipid phosphatase activities [ J ]. Biochem Biophys Res Com- mun, 2013, 440(2) :277-282.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部